Michael Freeman

Stock Analyst at Raymond James

(0.03)
# 3,964
Out of 4,667 analysts
1
Total ratings
n/a
Success rate
n/a
Average return

Stocks Rated by Michael Freeman

Bausch Health Companies
Jul 10, 2024
Initiates: Market Perform
Price Target: $8
Current: $8.19
Upside: -2.32%